ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

IMRX vs AMRN // DIVIDEND YIELD & FCF PAYOUT SAFETY

Immuneering Corporation (Class A) (NASDAQ) VS. Amarin Corporation plc (NASDAQ) • 15-METRIC TALLY: IMRX 0 — AMRN 5
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IMRX VS. AMRN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC IMRX AMRN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 56.60% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -12.20% -22.80 AMRN /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -17.49% 2.56% -20.05 AMRN /fcf-yield <GO>
Operating Margin — -23.50% — TIE /operating-margins <GO>
Net Profit Margin — -18.20% — TIE /net-margins <GO>
Revenue Growth (YoY) — -6.50% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety ACTIVE 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 6/9 -3.00 AMRN /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 43.1 46.6 -3.52 AMRN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $260.1M $262.8M -$2.7M AMRN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR IMRX REV AMRN REV IMRX GROSS % AMRN GROSS % IMRX FCF AMRN FCF
FY 2025 $0 $213.6M — 56.6% -$45.5M $6.7M
FY 2024 $0 $228.6M — 35.6% -$55.1M -$31.0M
FY 2023 $0 $306.9M — — -$49.0M $6.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IMRX // BETA —
AMRN // BETA —